The only way to prevent more massive stock dilution of the CUR stock is to offer the next round
of shares in the $20.00 range. Time will tell if that is feasible.
A Preferred Share Offering would have been better. But who knows? Maybe the common is headed for double digits?
Just Google ......Case No. C-08-02364 CW.....and read the PDF. This has the details before it moved to Maryland. We could potentially talking $Millions or $Billions.
CUR is just starting their FDA Trial for spinal cord repair and it appears the CUR approach is very "High Tech"!
Also CUR now has a FDA spinal cord trial (Neuralstem press release today).
Furthermore, there is this CNN Blog:
Here is an excerpt from the article:
Unlike the goal of the Geron trial (similar to StemCells’), which was to re-mylenate nerve cells to re-establish connections from the spine to the brain — like fixing an exposed wire by providing a new cover — the goal in this new trial is to “actually build new circuitry,” Neuralstem CEO Richard Garr said.
“The stem cells are injected directly into the area of the injury and jump the gap with the new circuitry we’ve built,” he said. “These cells don’t migrate to the site.”
In animal experiments, rats were injected with these human stem cells and recovered significant function in all lower extremity joints, according to Neuralstem. “The cells turned into neurons which grew a ‘remarkable’ number of axons that extended for ‘very long distances,’ bridging above and below the point of severance,” the company says in a statement, quoting study results from August 2012.
Neuralstem is trying to reconnect the nerve cells from below the injury site to cells above the point of injury to re-establish signals going to the brain, says Karl Johe, the company’s chairman and chief scientific officer, who developed the cells.
Johe says he hopes the first patient will have the surgery to get the stem cells by July. “And then it would occur about once a month,” he added.
As for the most recent research, which discussed a much simpler method called epidural stimulation, Johe says it’s a complimentary approach. This month, researchers showed that four patients who had had spinal cord injuries for more than two years were able to ‘reawaken’ their muscles, so to speak: move their legs when electrodes implanted in the back were turned on, providing electrical stimulation to the spinal cord.
“There has been debate whether the motor neuron circuitry is intact below the injury point,” Johe said. “So now we know for sure (it is).”
Minimizing stock dilution is apparently the biggest issue now. CUR needs to first get to $20.00 so that when more shares are issued there is less impact on dilution. The other option is a Preferred Share Offering
Needs to first get to $20.00 so that when more shares are issued there is less impact on dilution. The other option is a Preferred Share Offering
People wonder why investors are moving to Neuralstem Inc. - CUR ?
... Simple the market, investors, Wall Street remember when the STEM insiders dumped their shares before the 1 for 10 reverse split and then granted themselves boatloads of free shares. Despite the scientific advances STEM has made and the patents STEM owns; the markets appears to be stating that Neuralstem Inc. is the investors preference; and that fondness for Neuralstem Inc. may allow them to capture the neural science Multi $Billion market. Whether that will lead to a STEM bankruptcy? Only time will tell. The advancing stock price for Neuralstem will allow them to finance their global ambitions.
STEM: Potential bankruptcy analysis:
STEM: ANOTHER LOSS for the last quarter - approximately $6,962,000 Million loss
Again: ----- STEM after 21 Years has NEVER Shown a Profit
Total investment contribution: Approximately $350 Million
STEM: Continuous dilution for 21 years !!!!!!!
Reverse split was orchestrated by insiders.
The STEM insiders DUMPED their shares before the reverse split.
STEM insiders sold before the1 for 10 reverse split
After 1 for 10 reverse split – STEM insiders granted themselves boatloads of FREE shares
STEM stock has lost approximately 98% of its value from its al time high.....LOST 98% OF its VALUE!
Bottom line: Where is the $350 Million?
Shareholders need to stop the potential STEM bankruptcy that is on the horizon Do the math. How much more does STEM get diluted as the stock price falls?
1. There needs to be more major shareholders to implement positive changes.
2. A new STEM Board of Directors needs to be voted in
3. A new STEM CEO to be voted in
4. Cost controls implemented.
5. Salary reductions of 40% or more for STEM employees
6. The FREE share grants STEM employees received need to be taken back and receded